Search results for "Topic Highlight"

showing 10 items of 18 documents

Gut microbiota imbalance and colorectal cancer

2016

International audience; The gut microbiota acts as a real organ. The symbiotic interactions between resident micro-organisms and the digestive tract highly contribute to maintain the gut homeostasis. However, alterations to the microbiome caused by environmental changes (e.g., infection, diet and/or lifestyle) can disturb this symbiotic relationship and promote disease, such as inflammatory bowel diseases and cancer. Colorectal cancer is a complex association of tumoral cells, non-neoplastic cells and a large amount of micro-organisms, and the involvement of the microbiota in colorectal carcinogenesis is becoming increasingly clear. Indeed, many changes in the bacterial composition of the g…

0301 basic medicineColorectal cancer[SDV]Life Sciences [q-bio]enterotoxigenic bacteroides-fragilisGut floraCyclomodulin[ SDV.CAN ] Life Sciences [q-bio]/CancerTopic Highlightstreptococcus-gallolyticus infectionbiologyGastrointestinal MicrobiomeGastroenterologyGeneral Medicinecytolethal-distending toxin3. Good healthlactobacillus-acidophilus deficientIntestinesCell Transformation NeoplasticHost-Pathogen InteractionsInflammation MediatorsColorectal NeoplasmsVirulence Factorspolymerase-chain-reaction[SDV.CAN]Life Sciences [q-bio]/CancerGut microbiotaoxidative dna-damageMicrobiologyescherichia-coli strains03 medical and health scienceshelicobacter-pylori infectionmedicineAnimalsHumansMicrobiomeBacteria[ SDV ] Life Sciences [q-bio]inflammatory-bowel-diseaseCancerHelicobacter pyloribiology.organism_classificationmedicine.diseaseStreptococcus bovisColorectal cancerGastrointestinal MicrobiomeHépatologie et Gastroentérologie030104 developmental biologytoll-like receptorsOxidative stressImmunologyHépatology and GastroenterologyDysbiosiscolorectal cancer;gut microbiota;dysbiosis;cyclomodulin;oxidative;stress;enterotoxigenic bacteroides-fragilis;oxidative dna-damage;cytolethal-distending toxin;inflammatory-bowel-disease;streptococcus-gallolyticus infection;lactobacillus-acidophilus;deficient;helicobacter-pylori infection;polymerase-chain-reaction;escherichia-coli strains;toll-like receptorsDysbiosisDNA Damage
researchProduct

Metabolic syndrome in hypertensive patients: An unholy alliance

2014

For many years, it has been recognized that hypertension tends to cluster with various anthropometric and metabolic abnormalities including abdominal obesity, elevated triglycerides, reduced high-density lipoprotein cholesterol, glucose intolerance, insulin resistance and hyperuricemia. This constellation of various conditions has been transformed from a pathophysiological concept to a clinical entity, which has been defined metabolic syndrome (MetS). The consequences of the MetS have been difficult to assess without commonly accepted criteria to diagnose it. For this reason, on 2009 the International Diabetes Federation, the American Heart Association and other scientific organizations pro…

Arterial hypertensionmedicine.medical_specialtySettore MED/09 - Medicina InternaEnd organ damageType 2 diabetesOverweightLeft ventricular hypertrophyInsulin resistanceHypertensive retinopathyInternal medicineMedicineTopic HighlightAbdominal obesityTarget organ damageSettore MED/14 - Nefrologiabusiness.industryCardiovascular riskmedicine.diseaseMetabolic syndromeSettore MED/11 - Malattie Dell'Apparato CardiovascolareEndocrinologyCardiologyMetabolic syndromemedicine.symptomCardiology and Cardiovascular Medicinebusiness
researchProduct

Multifactorial nature of hepatocellular carcinoma drug resistance: Could plant polyphenols be helpful?

2007

Primary hepatocellular carcinoma (HCC) is a quite frequent tumor which results in high mortality and most often exhibits a poor response to present drug therapies. Clearly, a thorough understanding of the biological bases of this malignancy might suggest new strategies for its treatment. Here we examine the evidences that both "pharmacological" mechanisms (e.g. drug transporter or detoxification enzyme over-expression) and alterations in other critical factors, including the IAPs (Inhibitory of Apoptosis Proteins), involved in enhancement of cell survival and proliferation may determine the therapeutic resistance of HCC; we also underline the possible role in the process of the activation o…

DrugCarcinoma HepatocellularHepatocellular carcinomamedia_common.quotation_subjectDrug transporterDrug resistancePharmacologyBiologyMalignancyNF-κBInhibitor of Apoptosis ProteinsPlant polyphenolsPhenolsmedicineHumansInhibition of cell deathTopic HighlightsTranscription factorSensitizationmedia_commonFlavonoidsLiver NeoplasmsNF-kappa BGastroenterologyPolyphenolsGeneral MedicineIAPmedicine.diseaseNFKB1medicine.anatomical_structureDrug Resistance NeoplasmApoptosisDrug resistanceHepatocellular carcinomaCancer researchPlant PreparationsPhytotherapyWorld Journal of Gastroenterology
researchProduct

Endoscopic ultrasonography findings in autoimmune pancreatitis

2011

Endoscopic ultrasonography is an established diagnostic tool for pancreatic masses and chronic pancreatitis. In recent years there has been a growing interest in the worldwide medical community in autoimmune pancreatitis (AIP), a form of chronic pancreatitis caused by an autoimmune process. This paper reviews the current available literature about the endoscopic ultrasonographic findings of AIP and the role of this imaging technique in the management of this protean disease.

Endoscopic ultrasoundmedicine.medical_specialtyAUTOIMMUNEEndoscopic ultrasonographyDiseaseGastroenterologyAutoimmune DiseasesEndosonographyPANCREATITIS; AUTOIMMUNE; ENDOSCOPIC ULTRASOUND; IgG4 CHOLANGITISAutoimmune ProcessInternal medicinemedicineENDOSCOPIC ULTRASOUNDTopic HighlightPancreasIgG4 CHOLANGITISAutoimmune pancreatitismedicine.diagnostic_testbusiness.industryGastroenterologyGeneral Medicinemedicine.diseasemedicine.anatomical_structurePancreatitisPancreatitisImaging techniqueBile DuctsPancreasbusiness
researchProduct

Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acid.

2015

Gadoxetic acid improves detection and characterization of focal liver lesions in cirrhotic patients and can estimate liver function in patients undergoing liver resection. The purpose of this article is to describe the optimal gadoxetic acid study protocol for the liver, the unique characteristics of gadoxetic acid, the differences between gadoxetic acid and extra-cellular gadolium chelates, and the differences in phases of enhancement between cirrhotic and normal liver using gadoxetic acid. We also discuss how to obtain and recognize an adequate hepatobiliary phase.

Gadolinium DTPALiver CirrhosisGadoxetic acidCirrhotic livermedicine.medical_specialtySettore MED/09 - Medicina InternaCirrhosisCarcinoma HepatocellularGadoxetic acidContrast MediaGastroenterology030218 nuclear medicine & medical imagingResection03 medical and health sciences0302 clinical medicineInternal medicineMedicineHumansIn patientTopic HighlightSettore MED/12 - GastroenterologiaCirrhosimedicine.diagnostic_testbusiness.industryLiver NeoplasmsGastroenterologyHepatobiliary contrast materialMagnetic resonance imagingGeneral Medicinemedicine.diseaseMagnetic Resonance ImagingSettore MED/18 - Chirurgia GeneraleLiver030220 oncology & carcinogenesisHepatobiliary phaseLiver functionSettore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessCirrhosis; Gadoxetic acid; Hepatobiliary contrast materials; Liver; Magnetic resonance imaging; Gastroenterologymedicine.drugWorld journal of gastroenterology
researchProduct

Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients

2013

The introduction of tacrolimus in clinical practice has improved patient survival after organ transplant. However, despite the long use of tacrolimus in clinical practice, the best way to use this agent is still a matter of intense debate. The start of the genomic era has generated new research areas, such as pharmacogenetics, which studies the variability of drug response in relation to the genetic factors involved in the processes responsible for the pharmacokinetics and/or the action mechanism of a drug in the body. This variability seems to be correlated with the presence of genetic polymorphisms. Genotyping is an attractive option especially for the initiation of the dosing of tacrolim…

Graft Rejectionmedicine.medical_specialtyCYP3A5ATP Binding Cassette Transporter Subfamily BCYP3A4Genotypemedicine.medical_treatmentPharmacologyLiver transplantationBioinformaticsOrgan transplantationTacrolimusCalcineurin inhibitorMedicineCytochrome P-450 CYP3AHumansDrug Dosage CalculationsDosingATP Binding Cassette Transporter Subfamily B Member 1Topic HighlightKidney transplantLiver transplantKidney transplantationBiotransformationPolymorphism Geneticbusiness.industryPharmacogeneticGraft SurvivalGastroenterologyABCB1General Medicinemedicine.diseaseKidney TransplantationTacrolimusLiver TransplantationSingle nucleotide polymorphismTransplantationsurgical procedures operativePhenotypeTreatment OutcomePharmacogeneticsTacrolimuSettore BIO/14 - FarmacologiaPersonalized medicinebusinessPharmacogeneticsImmunosuppressive Agents
researchProduct

Immunological alterations in hepatitis C virus infection

2013

A higher prevalence of immunological processes has recently been reported in patients with hepatitis C virus (HCV) infection, focusing the attention of physicians and researchers on the close association between HCV and immune disorders. HCV lymphotropism represents the most important step in the pathogenesis of virus-related immunological diseases and experimental, virologic, and clinical evidence has demonstrated a trigger role for HCV both in systemic autoimmune diseases, such as rheumatoid arthritis, Sjogren syndrome, hemolytic anemia and severe thrombocytopenia, and in organ-specific autoimmune diseases, such as autoimmune hepatitis, thyroid disorders and diabetes. This review will out…

Hemolytic anemiaHepacivirusHepatitis C virusAutoimmunityAutoimmune hepatitisHepacivirusmedicine.disease_causeAutoimmunityAutoimmune DiseasesImmune systemmedicineAnimalsHumansTopic Highlightbiologybusiness.industryGastroenterologyAutoantibodyvirus diseasesGeneral MedicineHepatitis C Chronicmedicine.diseasebiology.organism_classificationVirologyHepatitis Cdigestive system diseasesRheumatoid arthritisImmunologybusiness
researchProduct

Protein phosphatases and chromatin modifying complexes in the inflammatory cascade in acute pancreatitis

2010

Acute pancreatitis is an inflammation of the pancreas that may lead to systemic inflammatory response syndrome and death due to multiple organ failure. Acinar cells, together with leukocytes, trigger the inflammatory cascade in response to local damage of the pancreas. Amplification of the inflammatory cascade requires up-regulation of pro-inflammatory cytokines and this process is mediated not only by nuclear factor κB but also by chromatin modifying complexes and chromatin remodeling. Among the different families of histone acetyltransferases, the p300/CBP family seems to be particularly associated with the inflammatory process. cAMP activates gene expression via the cAMP-responsive eleme…

Histone deacetylase 5biologyHistone methyltransferaseHistone H2Abiology.proteinCancer researchHistone acetyltransferaseHistone deacetylaseTopic HighlightSAP30CREBChromatin remodeling
researchProduct

Diabetic foot syndrome: Immune-inflammatory features as possible cardiovascular markers in diabetes

2015

Diabetic foot ulcerations have been extensively reported as vascular complications of diabetes mellitus associated with a high degree of morbidity and mortality. Diabetic foot syndrome (DFS), as defined by the World Health Organization, is an "ulceration of the foot (distally from the ankle and including the ankle) associated with neuropathy and different grades of ischemia and infection". Pathogenic events able to cause diabetic foot ulcers are multifactorial. Among the commonest causes of this pathogenic pathway it's possible to consider peripheral neuropathy, foot deformity, abnormal foot pressures, abnormal joint mobility, trauma, peripheral artery disease. Several studies reported how …

Inflammationmedicine.medical_specialtyPathologySettore MED/09 - Medicina InternaDiabetic foot syndrome; Inflammation; Cytokines; Cardiovascular risk; Markerbusiness.industryType 2 Diabetes MellitusType 2 diabetesDiseaseDiabetic foot syndromeMarkerCardiovascular riskmedicine.diseaseDiabetic footInsulin resistancePeripheral neuropathyInternal medicineDiabetes mellitusmedicineOrthopedics and Sports MedicineTopic HighlightbusinessCytokineFoot deformityWorld Journal of Orthopedics
researchProduct

Nanotechnology applications for the therapy of liver fibrosis.

2013

Chronic liver diseases represent a major global health problem both for their high prevalence worldwide and, in the more advanced stages, for the limited available curative treatment options. In fact, when lesions of different etiologies chronically affect the liver, triggering the fibrogenesis mechanisms, damage has already occurred and the progression of fibrosis will have a major clinical impact entailing severe complications, expensive treatments and death in end-stage liver disease. Despite significant advances in the understanding of the mechanisms of liver fibrinogenesis, the drugs used in liver fibrosis treatment still have a limited therapeutic effect. Many drugs showing potent ant…

Liver CirrhosisSettore MED/09 - Medicina InternaAntifibrotic drugs CirrhosiLiver fibrosisChemistry PharmaceuticalLiver fibrosisCellPharmacologyBioinformaticsAntifibrotic drugsLiver diseaseNanoparticleHepatic stellate cellsIn vivoFibrosisMedicineNanotechnologyAnimalsHumansTopic HighlightAdverse effectHepatic stellate cellDrug Carriersbusiness.industryTherapeutic effectGastroenterologyLiver fibrosiGeneral Medicinemedicine.diseasemedicine.anatomical_structureNanomedicineTreatment OutcomeCirrhosisHepatic stellate cellNanoparticlesbusinessWorld journal of gastroenterology
researchProduct